期刊
EMBO REPORTS
卷 17, 期 12, 页码 1872-1889出版社
WILEY
DOI: 10.15252/embr.201541489
关键词
gene networks; glioblastoma stem cells; MYC inhibition
资金
- Consiglio Nazionale delle Ricerche-Ministero dell'Istruzione
- Universita e Ricerca Epigen project
- Fondazione Umberto Veronesi
- Associazione Italiana per la Ricerca sul Cancro [15927]
MYC deregulation is common in human cancer and has a role in sustaining the aggressive cancer stem cell populations. MYC mediates a broad transcriptional response controlling normal biological programmes, but its activity is not clearly understood. We address MYC function in cancer stem cells through the inducible expression of Omomyca MYC-derived polypeptide interfering with MYC activitytaking as model the most lethal brain tumour, glioblastoma. Omomyc bridles the key cancer stemlike cell features and affects the tumour microenvironment, inhibiting angiogenesis. This occurs because Omomyc interferes with proper MYC localization and itself associates with the genome, with a preference for sites occupied by MYC. This is accompanied by selective repression of master transcription factors for glioblastoma stemlike cell identity such as OLIG2, POU3F2, SOX2, upregulation of effectors of tumour suppression and differentiation such as ID4, MIAT, PTEN, and modulation of the expression of microRNAs that target molecules implicated in glioblastoma growth and invasion such as EGFR and ZEB1. Data support a novel view of MYC as a network stabilizer that strengthens the regulatory nodes of gene expression networks controlling cell phenotype and highlight Omomyc as model molecule for targeting cancer stem cells.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据